British Journal of Dermatology · 2003 · 26 citations · 9 references
MedicineImmunologyPathologyClinical ImmunologyImmunopathologyInflammationImmunosuppressionInflammatory LesionsInflammatory Skin DiseasesInflammatory Skin DisordersInterferon ResponsesInterferon-based TherapyInflammatory Vulvar DisordersInhibition Of Interferon ResponsesInterferon-mediated PathologyTherapeutic CorticosteroidsTopical EmollientsTopical Imiquimod
Vulvitis circumscripta plasmacellularis (VCP) is a rare but well-described entity. It is notorious for its recalcitrant nature to various modalities of treatment. Intralesional interferon-alpha showed some promise, with complete resolution, but is coupled with the side-effect of myelosuppression. Topical imiquimod is a novel immune response modifier with the ability to induce the production of interferon-alpha. In this paper, we report two cases of VCP whose lesions were resistant to antibiotics, topical and oral corticosteroids, but resolved after a treatment trial with imiquimod.
9
Richard D. Baughman · Archives of Dermatology · 1974 · 53 citations
Medicine, Dermatology, Pathology +13